Revenue: The sum of all revenue fields included for a company's operating activities.
Zevra Therapeutics, Inc. (ZVRA) had Revenue of $20.40M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$20.40M |
$-3.10M |
|
$1.34M |
|
$19.06M |
|
$25.76M |
|
$-5.36M |
|
$3.44M |
|
$-1.92M |
|
$-1.92M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-3.10M |
|
$-5.36M |
|
$-4.02M |
|
54.09M |
|
54.09M |
|
$-0.06 |
|
$-0.06 |
|
| Balance Sheet Financials | |
$81.57M |
|
$0.42M |
|
$91.14M |
|
$172.71M |
|
$26.98M |
|
$60.09M |
|
$104.71M |
|
$131.69M |
|
$41.02M |
|
$-31.05M |
|
$41.02M |
|
54.68M |
|
| Cash Flow Statement Financials | |
$-8.22M |
|
$10.54M |
|
$1.61M |
|
$33.78M |
|
$37.34M |
|
$3.56M |
|
$3.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.02 |
|
-- |
|
-- |
|
0.59 |
|
1.46 |
|
93.41% |
|
-26.28% |
|
-26.28% |
|
-- |
|
-9.40% |
|
-15.19% |
|
$-8.32M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.53 |
|
1.62 |
|
55.66 |
|
-7.55% |
|
9.98% |
|
-1.79% |
|
-3.06% |
|
$0.75 |
|
$-0.15 |
|
$-0.15 |
|